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Difficulties in recognizing granulomatosis with polyangiitis (GPA) 
in elderly patients undergoing diagnostic thoracotomy twice — 
a report of two cases
Abstract
Granulomatosis with polyangiitis (GPA) is defined as a necrotizing granulomatous inflammation usually involving the upper and 
lower respiratory tract with necrotizing vasculitis affecting predominantly small to medium vessels. Because of non-specific 
symptoms, its radiological presentation, and the diversity of its clinical expression, it is not uncommon for it to be misdiagnosed, 
especially in the elderly. Although biopsy and histological examination seem to be essential for GPA diagnosis, their results are 
sometimes ambiguous and not helpful in making a decision. In this report, we present difficulties in the recognition of GPA in two 
elderly patients in whom, despite twice performing a diagnostic thoracotomy, GPA was recognized almost 4 and 6 years after 
the first symptoms. 
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Introduction
Granulomatosis with polyangiitis (GPA) is an 
uncommon immunologically-mediated systemic 
small-vessel vasculitis that is characterized by 
necrotizing granulomatous inflammation usually 
involving the upper and lower respiratory tract. 
There is also necrotizing vasculitis affecting pre-
dominantly small to medium vessels frequently 
coexisting with necrotizing glomerulonephritis 
[1]. It can occur at any age, although it is primarily 
a disease of older adults, with the peak age be-
tween 65 and 74 years old [2]. Because the upper 
respiratory tract is involved in 70–100% cases, 
classic otorhinolaryngologic symptoms — ear, 
nose and throat (ENT) manifestations — may be 
the first clinical presentation of the disease [3, 4]. 
Some patients may progress to a more generalized 
form of disease, usually involving the lungs, skin 
and/or kidneys, with pauci-immune necrotizing 
crescentic glomerulonephritis [5]. Classically, the 
acronym ELK is used to describe the common 
organ involvement in GPA (E – ENT, L – lungs, 
K – kidneys) [4].
According to the BSR (British Society for 
Rheumatology) and the BHPR (British Health 
Professionals in Rheumatology) guidelines, 
the following criteria must be fulfilled prior to 
a diagnosis of antineutrophil-cytoplasmic an-
tibodies (ANCA)–associated vasculitis (AAV): 
1) Symptoms and signs characteristic of systemic 
vasculitis; 2) At least one of the following: a) 
histological evidence of vasculitis and/or granu-
loma formation; b) positive serology for ANCA; 
c) specific indirect evidence of vasculitis; 3) No 
other diagnosis to account for symptoms or signs 
[6]. In practice, the diagnosis of GPA is usually 
based on clinical features and the presence of 
ANCA and is supported, whenever possible, by 
histology. 
Early diagnosis and treatment of GPA is 
important but, unfortunately, determining the 
correct diagnosis may cause difficulties, espe-
cially in the elderly. Systemic features (such as 
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malaise, fevere and weight loss) can appear not 
only in AAV, but also in other diseases and may 
last from weeks to months before evidence of 
specific organ involvement [3]. On the other hand, 
somtimes clinical symptoms are scarce and even 
surgical biopsy with histologic examination is not 
decisive. The present paper describes difficulties 
in the recognition of GPA in two elderly women 
in whom, despite performing diagnostic thora-
cotomy twice, GPA was barely recognized 4 and 
6 years after the first symptoms.  
Case report 1
A 71 year old female presented the first 
symptoms in 2013. She complained of a moderate 
cough and general malaise. A chest radiograph 
showed bilateral multiple pulmonary nodules and 
consolidations which were confirmed by a chest 
computed tomography (CT) scan in 2014. Results 
of standard laboratory blood tests were normal. 
There was no haematuria nor proteinuria, but 
there was an increased level of anti-myeloperoxi-
dase (MPO-ANCA) to 95 Ru/mL (relative units 
per milliliter, N ≤ 20) and an increased titer of 
the anti-nuclear antibodies (ANA) with the pre-
sence of double-stranded deoxyribonucleic acid 
(anti-dsDNA) antibodies and lupus anticoagulant 
(LA) proteins. During bronchoscopy, no pathology 
was found. In June 2014, the patient underwent 
diagnostic left thoracotomy with a wedge-like 
excision of the one nodule. In the resected spe-
cimen, inflammation composed of lymphocytes, 
plasma cells and neutrophils with focal interstitial 
fibrosis was described. Because the patient had 
mild symptoms and pulmonary function tests 
were normal, no treatment was administered. 
In August 2015, the control CT showed a par-
tial spontaneous regression of pulmonary lesions. 
However, in February 2016, clinical symptoms 
intensified. The patient now experienced a pro-
ductive cough, exercise dyspnoea and general 
malaise. The CT revealed the progression in the 
lungs: the persistent nodules had been enlarged 
and new nodules and ground-glass opacities 
appeared. The CT was unambiguous and the pa-
thology was still estimated to be interstitial lung 
disease. It is especially interesting to note that ba-
sed on previous serological findings, systemic lu-
pus erythematosus (SLE) was suspected. Because 
cancer was also considered, a transthoracic lung 
biopsy guided by CT was performed, but it sho-
wed only lymphocytes and neutrophils without 
neoplastic cells. A bronchoscopy was performed 
and no pathology was found. Results of mycobac-
terial and fungal cultures were negative. In March 
2016, the patient underwent a second diagnostic 
thoracotomy (this time, of the right side) with the 
wedge-like excision of the part of the middle and 
lower lobes. In the resected specimen, intensive 
fibrosis with chronic inflammation composed of 
giant cells and neutrophils was described. 
The patient was admitted to our Institute for 
the first time two months after the second thora-
cotomy. She was slightly weak and had a weak 
cough, but control CT again showed a spontaneo-
us partial regression of the pulmonary lesions. 
The histological revision of both of the resected 
specimens (taken in 2014 and 2016) revealed 
inflammation with granulomas containing giant 
cells, components of vasculitis, small focuses of 
alveolar hameorrhage, and organizing pneumonia. 
In conclusion, the pathology study suggested GPA 
as well as lesions in the course of connective 
tissue disease, especially SLE. The patient did not 
present with any other organ involvement except 
for the lungs and had no symptoms of lupus or 
other connective tissue disease. Laboratory tests 
(neutrophil counts, CRP, urine sediment) rema-
ined normal and furthermore, the initially positive 
ANCA and ANA tests had become negative. She 
was left under observation without treatment.
After nearly one year, in January 2017, the 
patient was admitted to our Institute again. She 
presented with a 3-week history of an increasin-
gly productive cough with blood-tinged sputum 
and increasing malaise. Additionally, she now 
also presented with nasal symptoms. Laboratory 
investigation showed an elevated white blood 
cell and neutrophil count, an increase in the CRP 
level, proteinuria and haematuria with glomerular 
filtration rate (GFR) impairment. The CT demon-
strated progression of the nodules in the lungs 
(Figure 1). Additionally, a head CT revealed sinu-
sistis with bone destruction. Serological testing 
showed a slightly elevated level of MPO-ANCA 
to 29 Ru/mL with a slightly positive ANA test. 
Based on the clinical course (lung, sinus, kidney 
involvement), histological examination and pre-
sence of ANCA, a diagnosis of GPA (MPO-ANCA 
AAV) was established. The patient was treated 
with prednisone and cyclophosphamide and 
responded well. Follow-up CT 3 months after 
treatment showed resolving pulmonary lesions 
and complete remission after 2 years. 
Case report 2
The disease of a 72-year old female also start-
ed in 2013 with abnormal laboratory test results 
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(a slight increase of the erythrocyte sedimentation 
rate-ESR). She did not have any clinical symp-
toms. Chest-X-ray showed a solid nodule 17 × 20 
× 11 mm (millimeter) in the right upper lobe con-
firmed by CT (Figure 2). During bronchoscopy, no 
pathology was found. Lung cancer was suspected 
and, in November 2013, the patient underwent 
right diagnostic thoracotomy with a wedge-like 
excision of the nodule, but histologic examination 
revealed only inflammation and necrosis, with 
negative mycobacterial staining. Results of labo-
ratory tests were normal and serological tests for 
ANCA and rheumatoid factor (RF) were negative. 
Because the patient had no clinical symptoms, 
it was decided to leave her under observation. 
Control CT performed after 6 months was normal. 
However, in 2015, CT examination showed a new 
nodule within the cavity, again in the right lung 
(Figure 3). In April 2015, the patient underwent 
a second right diagnostic thoracotomy with 
a wedge-like excision of the nodule. This time, the 
resected specimen revealed chronic inflammation 
composed of lymphocytes with focal fibrosis but 
without necrosis, and without cancer cells or 
mycobacteria. During further follow-up visits, 
the patient remained asymptomatic and control 
CT scans repeated 3 and 18 months after were 
normal. 
In 2017, an episode of haemoptysis occurred 
without other accompanying symptoms. The CT 
showed the appearance of two new cavitary nod-
ules in the right lung (segment 2 and 8). During 
A B
Figure 1 A, B. Chest CT (2017), lung windows, tranverse sections: the study shows progression of pulmonary lesions: more numerous small nodules 
and small ground-glass opacities in both upper lobes
Figure 2. Chest CT (2013), lung window, trnsverse section: a solitary 
spiculated nodule in the right upper lobe
Figure 3. Chest CT (2015), lung window, transverse section: the sudy 
compared with the prior CT (Figure 2) shows a new solid nodule — 
this time with the cavity — again in the right upper lobe, near a linear 
scar is visible associated with previous thoracotomy
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bronchoscopy, blood in the segmental bronchi 
was present, but results of mycobacterial and 
fungal cultures were again negative and revealed 
no malignancy. In histological examination of 
the bronchial slice, features of non-specific in-
flammation were found. Further, the fine needle 
aspiration biopsy was performed and showed 
inflammatory granulation without cancer cells. 
Results of laboratory tests and GFR remained 
normal, and ANCA were negative. During the fur-
ther follow-up period haemoptysis did not recur, 
but the positron emission computed tomography 
(PET-CT) performed a few months later demon-
strated an extension of the right lung nodular 
consolidations showing metabolic activity. 
The patient was admitted to our Institute for 
the first time in January of 2018. She was in good 
performance status without any abnormalities 
during examination. Laboratory investigation 
showed a normal blood cell count with a normal 
count of neutrophils, without anemia, and with 
a slight increase in the level of CRP to 12 mg/
dL (miligram per deciliter, N < 5). There was no 
erythrocyturia or proteinuria and the GFR was not 
impaired. Because the CT showed further minor 
progression in the lung, the patient underwent 
bronchoscopy but no pathology was found, and 
mycobacterial and fungal cultures were negative. 
The possibility of GPA was considered, and diag-
nostics were extended to CT of the sinuses/ears, 
but laryngological examination was negative. 
Serological tests showed a slight non-specific 
increase in anti-proteinase 3 (PR3-ANCA) con-
centration (22 Ru/mL, N ≤ 20). The histological 
revision of the resected 2013 and 2015 specimens 
revealed necrotizing granulomatous inflamma-
tion with histiocyte, neutrophil and lymphocyte 
infiltration centered on bronchi and bronchioles. 
The Grocott and periodic acid-Schiff (PAS) stains 
showed no fungal elements. The Ziehl-Neelsen 
stain was also negative. The pathology study 
suggested bronchocentric granulomtosis (BCG) 
requiring clinical differentiation with a less like-
ly bronchocentric form of GPA. The patient had 
no obvious evidence of the underlying disease 
of BCG (serum IgE level was not elevated, there 
was no fungal hypersensitivity, and no features of 
either an allergic bronchopulmonary aspergillosis 
or mycobacteria) and she did not have other organ 
involvement typical for vasculitis. Because the 
patient was asymptomatic, and the diagnosis was 
uncertain, it was decided not to initiate steroid 
therapy. During further follow-up visits in March 
and July 2018, the patient was feeling good. CT 
control scans showed variable pulmonary nod-
ules (spontaneous partial regression, after which 
nodules underwent a minor progression or inten-
sification of cavity). ANCA tests were negative. 
In January 2019, the patient was admit-
ted to the Institute due to deterioration of their 
well-being. She presented with a 4-week his-
tory of productive cough with nasal symptoms 
and general malaise. Laboratory investigations 
showed elevated blood cell and neutrophil count 
with an increase in the level of CRP to 30 mg/dL. 
Urine sediment and GFR were normal. The CT 
demonstrated progression of the cavitary nodules 
in the lungs (Figure 4). Additionally, sinusistis with 
bone destruction was found. In the serum ANCA, 
the concentration of PR3-ANCA increased to 42 
Ru/mL. Based on the clinical course (sinus, lung 
involvement), histological examination and pres-
ence of ANCA, a diagnosis of GPA (AAV PR3-AN-
CA) was established. The patient was treated with 
prednisone and cyclophosphamide and responded 
well. Follow-up CT scan 3 months after treatment 
showed resolving pulmonary lesions. 
Discussion
Diagnosis of GPA included specific symp-
toms, characteristic radiologic lesions and an 
appropriate microscopic pattern. Characteristic 
features for GPA are granulomatous inflammation 
of the upper and lower respiratory tracts in combi-
nation with necrotizing vasculitis affecting small 
vessels [1]. Typical symptoms included ENT ma-
nifestations [7]. Involvement of the lower respira-
tory tract was also common [8], and in over 30% 
of cases was asymptomatic [9]. Interestingly, in 
9% of patients, the lung was the only organ affec-
ted [9]. Radiographically, multiple and bilateral 
lung nodules occur in 40% to 70% of GPA cases, 
while cavitation occurs in 25% to 50% of these 
nodules [10]. The presence of ANCA, although 
not necessary, supports the diagnosis as it can be 
detected in up to 90% of patients with GPA [5]. To 
analyze our difficulty with diagnosing GPA, we 
are taking into account the following elements: 
the patients were older (> 65 years old), the first 
symptoms were connected only with the lungs, 
and the histological pattern did not contain the 
GPA features.
The accurate diagnosis of GPA can be dif-
ficult, especially in the elderly with disease 
initially limited to the lung like in our patients. 
The clinical presentation in older patients 
(> 65 years old) is similar to that seen in younger 
patients (< 65 years old), although certain featu-
res may be more common [11]. In older patients 
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the upper respiratory tract is less commonly 
involved, although lung involvement is not un-
common and more frequently, MPO-ANCA are 
present [12–14]. In the elderly, nonspecific symp-
toms often occur, and diagnosis is often delayed 
[2, 15]. Pulmonary nodules are a common radio-
logical manifestation, but not specific for GPA, 
and the differential diagnosis includes infections 
caused by mycobacteria and fungi, metastatic 
solid tumors and other granulomatous processes 
[16]. It has been reported that pulmonary-limited 
GPA can simulate pulmonary adenocarcinoma 
[17]. There have also been cases masquerading 
as tuberculosis before the correct diagnosis was 
made [18]. In our patients, solitary lung nodules 
were the first symptoms of disease and, for a few 
years (4 and 6, respectively), garnered the most 
attention in comparison with symptoms from 
other organs. Initially, metastatic cancer was 
also suspected, which has not been confirmed. 
Both patients underwent diagnostic thoracotomy 
twice and despite this, the appropriate primary 
diagnosis was not established. 
GPA is also a challenge for the pathologist 
because of its varied histological pattern. In 1988, 
Mark et al. [19] reviewed open lung biopsies from 
35 patients with GPA and established the relative 
diagnostic value of various histologic features. 
Authors concluded that the concept of GPA 
mainly as a vasculitis is too restrictive and does 
not include many cases with only extravascular 
histologic changes. Next, in 1990, Wegener him-
self wrote that „the vasculitis that accompanies 
the disease is a secondary feature that presents at 
a later stage and that this fact is often not heeded, 
and WG (Wegener’s granulomatosis) is frequently 
mistaken for a systemic vasculitis” [20]. Evidence 
of how diverse the histological findings in GPA 
can be were provided by Travis et al. in 1991 [21]. 
They reported the pulmonary pathologic features 
in 87 open lung biopsies from 67 patients dividing 
their manifestations into major and minor. The 
major manifeastations included: 1) parenchymal 
necrosis with neutrophilic microabscesses and 
large or small areas of geographic necrosis (found 
in 84% of biopsy specimens); 2) vasculitis (dif-
ferent vascular changes identified in 94%); and 
3) granulomatous inflammation accompanied 
by an inflmammatory infiltrate composed of a 
mixture of neutrophils, lymphocytes, plasma 
cells, histiocytes, and eosinophils. Other features 
such as: 1) interstitial fibrosis (26%); 2) alveolar 
Figure 4. Chest CT (2019), lung windows, trnsverse sections: the 
study shows progression of pulmonary lesions: A. The thick — wal-
led cavitary mass with an irregular internal wall localized at the base 
of the right upper lobe was increased; B. Nodules in the right lower 
lobe were increased and in one of them the cavity was appeared; C. 
The nodule in the left lower lobe was increased and the cavity was 
appeared within it
A B
C
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hemorrhage (49%); 3) tissue eosinophilia (100%); 
4) organizing intraluminal fibrosis (70%); 5) en-
dogenous lipoid pneumonia (59%); 6) lymphoid 
aggregates (37%); and 7) variety of bronchial/
bronchiolar lesions (51%) were classified as 
a minor manifestation. Although minor patholog-
ic lesions usually accompanied major lesions and 
were usually inconspicuous, in 18% of specimens 
a minor feature represented the dominant or ma-
jor finding. In 12% of specimens, active vasculitis 
affecting veins or arteries could not be identified 
[21]. Thus, the spectrum of pathologic features 
that can occur in pulmonary GPA is broad and is 
characterized by a wide variation which results 
in a complicated differential diagnosis and dif-
ficulities in establishing an appropriate disease. 
This was excellently illustrated in our patients. 
Both underwent diagnostic thoracotomy twice 
and, despite the large lung specimens, histological 
examination was not conclusive and did not sug-
gest another disease. In the first case, non-specific 
inflammation with fibrosis suggesting interstitial 
lung disease was dominant. In the second case, 
inflammation with necrosis was found, but the 
lesions were not specific and the results were 
not appropriately estimated. The revision of the 
specimens barely resulted in the suspicion of GPA 
although other diseases, such as SLE and BCG, 
were also considered. Our cases confirmed that 
the microscopic pattern in GPA does not always 
contain evident features of vasculitis or granu-
lomatosis with microabscesses and geographical 
necrosis as expected which makes it difficult to 
establish the diagnosis and extends the diagnos-
tic time. Here, it is important to underline that 
revision of these specimens by experts in lung 
pathology made the diagnosis more probable.
ANCA have been recognized as an important 
diagnostic marker in patients with AAV. The 
current guidelines underlined that a positive 
PR3- and/or MPO-ANCA result only contributes 
to the diagnostic work-up for AAV but is not 
diagnostic. As well, negative ANCA tests cannot 
be the basis for AAV exclusion [22]. It has been 
reported that about 10–20% of GPA patients can 
be ANCA–negative and that they usually present 
with localized disease especially limited to the 
upper and lower respiratory tracts [23]. However, 
it cannot be excluded that ANCA-negativity is 
the result of an imperfect diagnostic test: results 
of some studies indicated that performing detec-
tion tests with more different ELISA kits might 
improve the positivity of ANCA in AAV patients 
even from 41.4% to 69.0% [24]. On the other 
hand, ANCA are not specific markers for AAV and 
they have been reported in a huge variety of in-
flammatory conditions such as connective tissue 
diseases, infective diseases, malignancies, and in 
adverse drug reactions [7]. In SLE, for example, 
where there is a plethora of antibodies, ANCA 
frequency can be up to 25% [7]. In our patients, 
the chimericity of ANCA was excellently demon-
strated. During the multiple year duration of the 
disease, ANCA status was variable and an incre-
ase in ANCA concentration usually was not great 
which hindered the interpretation of their results. 
Additionally, in the first patient, anti-dsDNA were 
found despite the absence of SLE symptoms, 
causing some confusion. This case confirmed that 
serological tests should be performed only in the 
context of the clinical presentation. 
As already mentioned, the diagnosis of GPA 
can be difficult because its symptoms are varied 
and can mimic other diseases. Systemic features, 
if they occur, are not characteristic and may 
last from weeks to months before evidence of 
specific organ involvement. In a small study by 
Gomez-Gomez et al. [16], the average duration 
of symptoms to determine the diagnosis was 
5.3 months, while in a study by Kumar et al. 
[18], median disease duration at diagnosis was 
20 months. Interesting data was presented by 
Yacyshyn et al. [25]: they presented the results 
of an anonymous survey in which respondents 
self-reported a diagnosis of GPA. In the patients’ 
opinion, 36.4% of GPA cases had a delay in dia-
gnosis of more than 1 year, and 12.3% reported 
a delay for more than 3 years. In our patients, 
disease duration at diagnosis was 4 and 6 years 
respectably after initial presentation despite 
diagnostic thoracotomy having been comple-
ted twice. The diagnosis was difficult because 
none of the diagnostic compartments were cha-
racteristic for GPA: there were neither clinical 
symptoms, radiological lesions, nor histologic 
patterns. In the elderly, the typical ENT symp-
toms are less serious. The changing pulmonary 
lesion character and intensity during several 
years of observation which was described in our 
patients is a rather rare phenomenon. Another 
element that makes recognition difficult was 
the nonspecific and incomplete histological 
pattern. However, both meticulous monitoring 
and thorough histological revision allowed us 
to determine the appropriate diagnosis and to 
administrate effective treatment. 
In summary, our two patients represent how 
GPA is a great diagnostic challenge, especially in 
the elderly. They excellently showed the diagno-
stic difficulties of isolated pulmonary nodules 
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and/or cavitations which usually needed invasive 
procedures to rule out infection or metastatic can-
cer. The approach requires a critical analysis of 
clinical and radiographical features, biomarkers, 
cultures and histological examinations via lung 
biopsy even by thoracotomy at the beginning and 
not only on follow up. An analysis of the presen-
ted cases leads to several conclusions. Firstly, the 
histological examination is not sufficient enough 
to establish a GPA diagnosis on its own, especial-
ly when the microscopic picture does not show 
evident features of vasculitis or granulomatosis 
with microabscesses. Secondly, the histological 
diagnosis of GPA is challenging and requires a lot 
of experience from the pathologist. Thirdly, solita-
ry pulmonary nodules, after exclusion of neopla-
stic characteristics, require precise observation 
with regards to the development of GPA. And 
finally, the cases show that both experience and 
close cooperation between the clinicians and the 
pathologists are necessary in order to determine 
the appropriate diagnosis. 
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